• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2 Unprofitable Stocks to Research Further and 1 We Brush Off

By: StockStory
November 02, 2025 at 23:39 PM EST

HCAT Cover Image

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Unprofitable companies face an uphill battle, but not all are created equal. Luckily for you, StockStory is here to separate the promising ones from the weak. That said, here are two unprofitable companies investing heavily to secure market share and one that may never reach the Promised Land.

One Stock to Sell:

Health Catalyst (HCAT)

Trailing 12-Month GAAP Operating Margin: -28%

Built on its "Health Catalyst Flywheel" methodology that emphasizes measurable outcomes, Health Catalyst (NASDAQ: HCAT) provides data and analytics technology and services that help healthcare organizations manage their data and drive measurable clinical, financial, and operational improvements.

Why Do We Steer Clear of HCAT?

  1. Muted 5.4% annual revenue growth over the last two years shows its demand lagged behind its software peers
  2. Customer acquisition costs take a while to recoup, making it difficult to justify sales and marketing investments that could increase revenue
  3. Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution

Health Catalyst is trading at $3.23 per share, or 0.7x forward price-to-sales. Check out our free in-depth research report to learn more about why HCAT doesn’t pass our bar.

Two Stocks to Watch:

Arlo Technologies (ARLO)

Trailing 12-Month GAAP Operating Margin: -1.9%

Originally spun off from networking equipment maker Netgear in 2018, Arlo Technologies (NYSE: ARLO) provides cloud-based smart security devices and subscription services that help consumers and businesses monitor and protect their homes, properties, and loved ones.

Why Is ARLO on Our Radar?

  1. Operating profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
  2. Incremental sales over the last two years have been highly profitable as its earnings per share increased by 434% annually, topping its revenue gains
  3. Free cash flow margin grew by 17.4 percentage points over the last five years, giving the company more chips to play with

At $19.40 per share, Arlo Technologies trades at 29x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free for active Edge members.

StepStone Group (STEP)

Trailing 12-Month GAAP Operating Margin: -37.8%

Operating as both an advisor and asset manager with over $100 billion in assets under management, StepStone Group (NASDAQ: STEP) is an investment firm that provides clients with access to private market investments across private equity, real estate, private debt, and infrastructure.

Why Do We Love STEP?

  1. Annual revenue growth of 27.7% over the past two years was outstanding, reflecting market share gains this cycle
  2. Additional sales over the last two years increased its profitability as the 33.8% annual growth in its earnings per share outpaced its revenue
  3. ROE punches in at 24.6%, illustrating management’s expertise in identifying profitable investments

StepStone Group’s stock price of $61.06 implies a valuation ratio of 30x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free for active Edge members.

Stocks We Like Even More

Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
News headline image
Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast ↗
Today 10:21 EST
Via MarketBeat
Tickers CRM GWRE OKTA RBRK SNOW
News headline image
Five Below and Dollar Tree Earnings Signal a Shopper Shift ↗
Today 7:15 EST
Via MarketBeat
Tickers DLTR FIVE
News headline image
Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead? ↗
December 06, 2025
Via MarketBeat
Tickers ULTA
News headline image
Gates Foundation Sells MSFT Stock—Should Investors Be Worried? ↗
December 06, 2025
Via MarketBeat
Tickers MSFT
MarketBeat Week in Review – 12/1 - 12/5 ↗
December 06, 2025
Via MarketBeat
Tickers AMZN COST CRWD GOOGL IBIT MDB

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap